Cargando…
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) research and antiviral discovery are hampered by the lack of a cell-based virus replication system that can be readily adopted without biosafety level 3 (BSL-3) restrictions. Here, the construction of a noninfectious SARS-CoV-2 reporter re...
Autores principales: | He, Xi, Quan, Shuo, Xu, Min, Rodriguez, Silveria, Goh, Shih Lin, Wei, Jiajie, Fridman, Arthur, Koeplinger, Kenneth A., Carroll, Steve S., Grobler, Jay A., Espeseth, Amy S., Olsen, David B., Hazuda, Daria J., Wang, Dai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053989/ https://www.ncbi.nlm.nih.gov/pubmed/33766889 http://dx.doi.org/10.1073/pnas.2025866118 |
Ejemplares similares
-
SARS-CoV-2 replicon for high-throughput antiviral screening
por: Zhang, Qiu-Yan, et al.
Publicado: (2021) -
siRNA Screening of a Targeted Library of DNA Repair Factors in HIV
Infection Reveals a Role for Base Excision Repair in HIV
Integration
por: Espeseth, Amy S., et al.
Publicado: (2011) -
543. Molnupiravir Maintains Antiviral Activity Against SARS-CoV-2 Variants In Vitro and in Early Clinical Studies
por: Grobler, Jay, et al.
Publicado: (2021) -
Development of A MERS-CoV Replicon Cell Line for Antiviral Screening
por: Chen, Jing, et al.
Publicado: (2021) -
High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles
por: Lücke, Arlen-Celina, et al.
Publicado: (2022)